BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND PTPRT, KIAA0283, 11122, ENSG00000196090, O14522, RPTPrho, RP5-1121H13_2 AND Treatment
31311 results:

  • 1. Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial).
    Lacombe K; Moh R; Chazallon C; Lemoine M; Sylla B; Fadiga F; Le Carrou J; Marcellin F; Kouanfack C; Ciaffi L; Sartre MT; Sida MB; Diallo A; Gozlan J; Seydi M; Cissé V; Danel C; Girard PM; Toni TD; Minga A; Boyer S; Carrieri P; Attia A;
    Sci Rep; 2024 May; 14(1):10244. PubMed ID: 38702350
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Efficacy and safety of transarterial chemoembolization combined with targeted therapy and immunotherapy versus with targeted monotherapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
    Feng J; Zhao Y; Zhai L; Zhou J
    Medicine (Baltimore); 2024 May; 103(18):e38037. PubMed ID: 38701263
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The clinical significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib and PD-1 inhibitors.
    Sun W; Yin X; Liu X; Wei J; Yu M; Li W; Ding X; Chen J
    Front Immunol; 2024; 15():1380477. PubMed ID: 38698848
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Predictive factors of 90-day mortality after curative hepatic resection for hepatocellular carcinoma: a western single-center observational study.
    Vaghiri S; Lehwald-Tywuschik N; Prassas D; Safi SA; Kalmuk S; Knoefel WT; Dizdar L; Alexander A
    Langenbecks Arch Surg; 2024 May; 409(1):149. PubMed ID: 38698255
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Tebentafusp in the treatment of metastatic uveal melanoma - the first patient treated in the Czech Republic.
    Klabusay M; Bábková B
    Klin Onkol; 2024; 38(2):134-138. PubMed ID: 38697822
    [TBL] [Abstract] [Full Text] [Related]  

  • 6.
    Waziri P; Auta R; Imam MU; Chindo BA; Ladan Z; Mohammed Z; Wayah S; Mohammed J; Tahir MI; Ahmad AE; Alhassan Y; Tyoapine D; Agbaji AS
    J Evid Based Integr Med; 2024; 29():2515690X241251558. PubMed ID: 38689490
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trial.
    Zeng TM; Jiang TY; Yang G; Cheng Z; Lou C; Wei W; Tao CJ; Hu S; Wang H; Cui XW; Tan YX; Dong LW; Wang HY; Yuan ZG
    Clin Transl Med; 2024 May; 14(5):e1675. PubMed ID: 38689424
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A retrospective clinical analysis of 11 cases of PEComa from different sites.
    Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
    World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Efficacy of microwave ablation with parallel acupuncture guided by ultrasound in treating single hepatocellular carcinoma in high-risk areas: A retrospective analysis of 155 patients.
    Liu S; Zhou P; Shen Q; Qian G
    J Cancer Res Ther; 2024 Apr; 20(2):547-554. PubMed ID: 38687924
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Risk factors associated with lymph node metastasis in early-stage distal gastric cancer.
    Yu Z; Liang C; Li R; Gao J; Gao Y; Zhou S; Li P
    World J Surg; 2024 Jan; 48(1):151-162. PubMed ID: 38686759
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (IRCC).
    Saberzadeh-Ardestani B; Khosravi AA; Mansour-Ghanaei F; Vahedi H; Baniasadi N; Seyyedmajidi M; Parhizkar B; Hormati A; Naghshbandi SJ; Matin S; Hassan Zadeh AA; Taghvaei T; Bahrami M; Rafeey M; Ahadi M; Vossoughinia H; Muosavi H; Gheibi S; Hosseini-Hemmatabadi RS; Yazdanbod A; Matinkhah S; Sheikh Esmaeili F; Fakheri H; Moosavy SH; Maleki I; Nasseri-Moghaddam S; Khosravi B; Farahmand F; Najafi M; Alimadadi H; Malekzadeh M; Anushiravani A; Kasaeian A; Alatab S; Sadeghi A; Radmard AR; Kolahdoozan S; Rajabi Z; Sima AR
    Arch Iran Med; 2024 Apr; 27(4):183-190. PubMed ID: 38685844
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. No-Touch Radiofrequency Ablation Using Twin Cooled Wet Electrodes for Recurrent Hepatocellular Carcinoma Following Locoregional treatments.
    Hong SJ; Kim JH; Yoon JH; Park JH; Yoon JH; Kim YJ; Yu SJ; Cho EJ; Lee JM
    Korean J Radiol; 2024 May; 25(5):438-448. PubMed ID: 38685734
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients.
    Daher D; Seif El Dahan K; Rich NE; Tayob N; Merrill V; Huang DQ; Yang JD; Kulkarni AV; Kanwal F; Marrero J; Parikh N; Singal AG
    JAMA Netw Open; 2024 Apr; 7(4):e248755. PubMed ID: 38683607
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Longitudinal analysis of liver transplant candidates for hepatocellular carcinoma in a single center.
    Ho CM; Lee PH; Cheng HY; Hsaio CY; Wu YM; Ho MC; Hu RH
    Langenbecks Arch Surg; 2024 Apr; 409(1):143. PubMed ID: 38683375
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
    Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate.
    Pitakkitnukun P; Pongpitakmetha T; Suttichet TB; Sukkummee W; Chariyavilaskul P; Polprasert C
    Sci Rep; 2024 Apr; 14(1):9695. PubMed ID: 38678107
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Albumin-bilirubin Grade as Prognostic Indicator for Recurrent Hepatocellular Carcinoma Needing Repeat liver Resection.
    Gon H; Komatsu S; Omiya S; Kido M; Fukushima K; Urade T; Yoshida T; Arai K; Ishida J; Nanno Y; Tsugawa D; Yanagimoto H; Toyama H; Fukumoto T
    Anticancer Res; 2024 May; 44(5):2031-2038. PubMed ID: 38677757
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Safety and tolerability of OP-724 in patients with haemophilia and liver cirrhosis due to HIV/HCV coinfection: an investigator-initiated, open-label, non-randomised, single-centre, phase I study.
    Kimura K; Tanuma J; Kimura M; Imamura J; Yanase M; Ieiri I; Kurosaki M; Watanabe T; Endo T; Yotsuyanagi H; Gatanaga H
    BMJ Open Gastroenterol; 2024 Apr; 11(1):. PubMed ID: 38677720
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. REPeated mAgnetic resonance Image-guided stereotactic body Radiotherapy (MRIg-reSBRT) for oligometastatic patients: REPAIR, a mono-institutional retrospective study.
    Chiloiro G; Panza G; Boldrini L; Romano A; Placidi L; Nardini M; Galetto M; Votta C; Campitelli M; Cellini F; Massaccesi M; Gambacorta MA
    Radiat Oncol; 2024 Apr; 19(1):52. PubMed ID: 38671526
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Non-small cell lung cancer and immune checkpoint inhibitor therapy: does non-alcoholic fatty liver disease have an effect?
    Li Y; Gong B; Guo Y; Liu W; Chen C; Jiang S; Pan F; Song J; Yang L; Zhou G
    BMC Cancer; 2024 Apr; 24(1):535. PubMed ID: 38671373
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1566.